Search for: "Endo Pharmaceutical"
Results 221 - 240
of 254
Sort by Relevance
|
Sort by Date
10 Feb 2010, 4:47 pm
Mylan Pharmaceuticals Inc. [read post]
14 Jan 2010, 7:55 am
Download file In a letter to Amylin Pharmaceuticals regarding Byetta (exenatide) , the agency said that representatives speaking at the Endocrine Society’s Annual Meeting (ENDO) in June promoted the drug for off-label uses, saying that it could be used as a stand-alone diabetes treatment, when Byetta was only approved at the time for use with other diabetes medications. [read post]
11 Dec 2009, 11:13 am
This December 2009 FDA MedWatch alert also provided links to: (1) "Prescribing Information" -- also known as the package insert or label -- for Voltaren Gel; and, (2) a "Dear Healthcare Professional Letter" -- commonly called a "Dear Doctor" letter -- from Endo Pharmaceuticals Inc. and Novartis Consumer Health, Inc., the companies responsible for Voltaren Gel in the U.S. [read post]
1 Dec 2009, 9:45 am
(patent infringement) 11/19: Allergan Inc., Allergan USA Inc., Allergan Sales, LLC, Endo Pharmaceuticals Solutions Inc., Supernus Pharmaceuticals Inc. v. [read post]
8 Oct 2009, 6:05 am
Reddy’s, Barr and Purepac (Patent Baristas) Renagel (Sevelamer) – US: Genzyme files patent infringement suit against Endo Pharmaceuticals following Para IV challenge (Patent Docs) Roundup Ready cotton seed – US: Monsanto files patent infringement suits against Brent M Hargrove and Larry H Lytle based on defendants’ use of cotton seed produced from earlier planted Roundup Ready cotton seed (Patent Docs) Seroquel (Quetiapine) – US:… [read post]
4 Oct 2009, 4:56 pm
Endo Pharmaceuticals Inc. 1:09-cv-02589; filed October 1, 2009 in the District Court of Maryland Infringement of U.S. [read post]
28 Aug 2009, 8:11 am
(patent infringement) 8/6: Ethicon Endo-Surgery Inc. v. [read post]
15 Jul 2009, 5:15 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: European Commission Competition DG releases final report on pharmaceutical sector (IPKat) (PatLit) (BLOG@IP::JUR) (IAM) (Managing Intellectual Property) (Intellectual Property Watch) (The SPC Blog) (IAM) US: Follow-on biologics proposals considered by US Senate HELP Committee; Committee passes amendment for 12-year biologics exclusivity period… [read post]
13 Jul 2009, 7:46 pm
-based Endo Pharmaceuticals for $20 million up front and the potential for over $110 million more; and Allostera raised $17 million in venture capital. [read post]
4 Mar 2009, 11:00 pm
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: BIO meets the press: economic health of the biotech industry; follow-on biologics; patent reform (Patent Docs) (Patent Docs) (Intellectual Property Watch) Vinorelbine ditartrate – Belgium: Brussels Court of First Instance rules on whether SPC protection extends to use of an active ingredient before it is transformed into medicinal… [read post]
4 Mar 2009, 7:08 am
To market the Chronogesic, DURECT partnered with ENDO (a wholly owned subsidiary of Endo Pharmaceutical Holdings). [read post]
2 Mar 2009, 9:28 pm
By Suresh Pillai --Penwest and Endo Announce a Settlement of Opana ® ER Litigation On February 20, Penwest Pharmaceuticals, based in Danbury, CT, and Endo Pharmaceuticals jointly announced a settlement of their litigation with Morristown, NJ-based Actavis South Atlantic LLC over the production and sale of generic formulations of Opana ® ER (oxymorphone hydrochloride) (see "Court Report," July 20, 2008). [read post]
27 Feb 2009, 5:00 am
USA, Inc (Orange Book Blog) (FDA Law Blog) (Patent Baristas) (Law360) (Patent Docs) (Patent Prospector) (Patently-O) (GenericsWeb) (Hal Wegner) Famvir (Famciclovir) – US: Teva loses bid to toss Novartis wilful infringement claims over Famvir (Law360) Fentora (Fentanyl) – US: Barr alleges Cima and Cephalon’s patent suit just a delay tactic (Law360) Integrilin (Eptifibatide) – US: Schering alleges patent infringement following Teva’s Para IV… [read post]
22 Jan 2009, 2:24 am
SFAS 141(R) Doesn â [read post]
9 Jan 2009, 8:21 pm
By Jason Derry --Endo to Acquire Indevus On January 5, 2009, Endo Pharmaceuticals Holdings Inc. announced that it will buy Indevus Pharmaceuticals Inc. for an initial payment of about $370 million and an additional $267 million, based on certain milestones. [read post]
9 Jan 2009, 11:14 am
Five Am Law 100 firms help close a huge tobacco deal, while Skadden adds a pharmaceutical acquisition to its portfolio, and O'Melveny aids in the sale of two TV Guide properties. [read post]
27 Oct 2008, 1:37 am
By Sherri Oslick --About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring.Endo Pharmaceuticals Inc. et al. v. [read post]
25 Oct 2008, 12:03 am
Sandoz, Inc (Law360) (Hal Wegner) (Patently-O) (Patent Prospector) (PLI) Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust Litigation (IP Law Observer) Lescol (Fluvastatin) - US: Mylan confirms first-to-file patent challenge to Lescol by Novartis (SmartBrief) Levaquin (Levofloxacin) - UK: Levofloxacin SPC valid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd & Anor (IPKat)… [read post]
29 Aug 2008, 1:25 pm
: (IP finance), Facebook removes international access to Scrabulous, except from India: (Ars Technica), (Techdirt), Reverse engineering can resolve conflict between standardisation and competition: (Techdirt), Benefits of piracy aren’t always in the expected places: (Techdirt) Events 1-3 September: Federation of Indian Chambers of Commerce and Industry, Department of Industrial Property and Promotion, and WIPO conference on ‘Development and IP: Building synergies… [read post]
2 Aug 2008, 12:54 am
, (Daily Dose of IP), 20 August – Bill Patry Copyright Blog speaking on copyright – Melbourne: (Patry Copyright Blog), (LawFont.com), 21 August – Bill Patry Copyright Blog speaking on copyright – Canberra: (Patry Copyright Blog), (LawFont.com), 22 August – Bill Patry Copyright Blog speaking on copyright – Sydney: (Patry Copyright Blog), (LawFont.com), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat),… [read post]
